A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the ...

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

Huntington's disease (HD) has long been impossible to cure, but new research is finally giving fresh hope. HD is a ...

For those born with certain types of congenital deafness, the cochlear implant has been a positive and enabling technology.

Sadly, there is no cure for Huntington’s disease. But a couple new research papers suggests this may be about to change.

By joining forces, IDT will pair its nearly 40-year legacy of quality and service, as well as its global presence, with ...

The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...

It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene ...

CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations ...

Beam Therapeutics Inc. pivots from platform story to execution-driven thesis, with regulatory clarity accelerating BEAM-302 ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...